Industry reports
May_CDMO Topics｜Asia CDMOs are back with new opportunities
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
Global Biotech CDMO (Contract Development and Marketing Organization) ...read more
April_Tariff War｜Tariff War Extends, Drugs Become New Concerns
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
Under Trump's reciprocal tariffs, medical devices and equipment have been victimized and included in the scope of tariff increase, which is a direct hit. ...read more
April_Tariff War｜U.S. reciprocal tariffs hit the global biotech and pharmaceutical industry, and the industry is "crapping its pants".
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
The U.S. is wielding the tariff stick again, and on 4/2 Trump signed an executive order on "reciprocal tariffs", imposing more than 180 tariffs on more than 180 countries worldwide. ...read more
March_Special Topics｜Changes in the U.S. Pharmaceutical Industry under the Trump Administration
U.S. government spending cuts are shaking up the broader U.S. healthcare ecosystem, seemingly announcing that the era of abundant U.S. healthcare funding is over, and whether or not it will embark on an environment of pharmaceutical austerity remains to be seen, but optimization and refinement of the ...read more
January_CES 2025 Immersed in GAI+AI, Continuously Accelerating Innovation and Development in the Digital Health Industry (Next)
Brain Neurotronics enhances mental health, allowing for a wider range of brain health technology applications.
Under AARP Agetech 2 ...read more
January_CES 2025｜Immersive GAI+AI, Continuing to Accelerate Digital Health Industry Innovation and Development (Up)
Executive summary
CES 2025 is based on Everything is GAI+AI, GAI+AI Immersion ( ...read more
December_2025 Trend Forecast｜Great Health Industry Key Trend Forecasts
- 2025Health Industry Executive Summary
December_Special Topics｜Trump 2.0: Analyzing the New Pharmaceutical Policy
Trump's New Deal on Drugs: Reducing Health Care Burdens and Deregulation Become Important Journeys
Make America Great Again (Make Americ) ...read more
